CCMG
IART icon

Clark Capital Management Group’s Integra LifeSciences IART Stock Holding History

Clark Capital Management Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-39,444
Closed -$2.26M – 352
2023
Q1 		$2.26M Buy
39,444
+862
+2% +$48.6K 0.03% 202
2022
Q4 		$2.16M Buy
+38,582
New +$1.96M 0.02% 206
2020
Q2 		– Sell
-32,424
Closed -$1.45M – 315
2020
Q1 		$1.45M Buy
+32,424
New +$1.7M 0.04% 188

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clark Capital Management Group's IART Position: Q2 2023 in Review

Clark Capital Management Group sold out of Integra LifeSciences (IART) in Q2 2023, closing a stake of 39,444 shares — an estimated $2.26M sold.

Clark Capital Management Group first reported a position in IART in Q1 2020 and held it in 3 quarters. The position peaked at $2.26M in Q1 2023. 283 funds tracked by Wall St. Rank hold IART as of Q2 2023.

  • Clark Capital Management Group reported no remaining Integra LifeSciences position as of Q2 2023 after selling out during the quarter.
  • Clark Capital Management Group sold 39,444 Integra LifeSciences shares in Q2 2023, an estimated $2.26M.
  • Clark Capital Management Group first reported a position in Integra LifeSciences in Q1 2020 and held it in 3 quarters.
  • Clark Capital Management Group's Integra LifeSciences position peaked at $2.26M in Q1 2023.
  • 283 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2023.

Based on Clark Capital Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.